PharmaCan Capital to Sell 6.7mm Shares at $2.25


PharmaCan Capital Announces $15 Million Bought Deal

TORONTO, ONTARIO–(Marketwired – Feb. 14, 2017) –

PharmaCan Capital Corp., doing business as Cronos Group (TSXV: MJN) (OTC: PRMCF) (“Cronos” or the “Company”) is pleased to announce that it has entered into a letter of engagement with Eight Capital on

... read more at: